Sign In
Buy BMY
$56.60
+1.88 (+3.44%)
At Close: Jun 04, 2026
Bristol Myers Squibb Provides Update on Phase 3 CheckMate -73L Trial
04:30pm, Friday, 10'th May 2024
PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #NSCLC--Bristol Myers Squibb Provides Update on Phase 3 CheckMate -73L Trial.
Bounce Alert: 3 Large Caps With RSIs Too Good To Ignore
11:45am, Friday, 10'th May 2024
Savvy stock investors often look for bargains using the Relative Strength Index (RSI). This technical tool evaluates a stock's performance over the last 14 days and assigns a value from 0 to 100.
2 Beaten-Down Stocks to Buy and Hold for 10 Years
09:45am, Friday, 10'th May 2024
Bristol Myers and Pfizer have experienced declining sales lately. However, both companies are rejuvenating their lineups.
Maximize Your Dividends: 7 Stocks Trading Under $50 with 5%+ Yields
02:22pm, Monday, 06'th May 2024
Investing in dividend stocks is one of the surest paths to building long-term wealth. Those who reinvest dividends compound their returns, building sustainable wealth in the long run.
PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #BLA--U.S. Food and Drug Administration Accepts Bristol Myers Squibb's Application for Subcutaneous Nivolumab (nivolumab and hyaluronidase).
PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #CRC--European Medicines Agency Validates Bristol Myers Squibb's Application for Opdivo (nivolumab) Plus Yervoy (ipilimumab) for the First-Line.
Uncover the Potential: 3 Discounted Stocks Ready for a Comeback
06:00am, Monday, 06'th May 2024
Sometimes a good stock just has a bad day. Other times, what was once a booming company simply can no longer provide the same returns.
Could Investing $100,000 in Bristol Myers Squibb Stock Make You a Millionaire?
09:30am, Friday, 03'rd May 2024
Bristol Myers stock is trading at multi-year lows and offers a sizable dividend yield. The drugmaker's scary-looking net loss is largely attributable to one-time outlays.
If You'd Invested $1,000 in Bristol Myers Squibb 5 Years Ago, Here's How Much You'd Have Today
07:15am, Friday, 03'rd May 2024
Bristol Myers Squibb has underperformed the S&P 500 over the past five years. The company's falling stock has driven up its dividend yield -- to a fat 4.9%.
Bristol-Myers Squibb: A Lost Decade?
09:01pm, Thursday, 02'nd May 2024
Bristol-Myers Squibb's share price reached new all-time highs in 2022, driven by a strong pipeline and new approvals. However, doubts arose about the company's ability to close the patent gap and achi
Should You Pick Bristol Myers Squibb Stock At $45?
07:00am, Wednesday, 01'st May 2024
Bristol Myers Squibb Bristol Myers Squibb (NYSE: BMY) recently reported its Q1 results, with revenues and earnings above the street estimates. The company reported revenue of $11.9 billion and an adju
Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It
10:00am, Tuesday, 30'th Apr 2024
Recently, Zacks.com users have been paying close attention to Bristol Myers (BMY). This makes it worthwhile to examine what the stock has in store.
Judge rejects J&J, Bristol Myers Squibb challenges to Medicare drug price negotiations
06:22pm, Monday, 29'th Apr 2024
The decision is another win for the Biden administration in a bitter legal fight with several drugmakers over the constitutionality of the price talks.
J&J, Bristol Myers lose challenges to US drug price negotiation program
05:57pm, Monday, 29'th Apr 2024
A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S
2 Very Cheap Turnarounds Yielding Up To 7%
08:15am, Saturday, 27'th Apr 2024
AT&T and Bristol-Myers Squibb are two beaten-down stocks with attractive dividend yields. AT&T has solid operating fundamentals and a low valuation, while Bristol-Myers Squibb has a strong pipeline an
